financetom
Business
financetom
/
Business
/
Alignment Healthcare Insider Sold Shares Worth $420,293, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alignment Healthcare Insider Sold Shares Worth $420,293, According to a Recent SEC Filing
Mar 13, 2025 2:25 PM

05:10 PM EDT, 03/13/2025 (MT Newswires) -- Dawn Christine Maroney, President, on March 12, 2025, sold 27,243 shares in Alignment Healthcare ( ALHC ) for $420,293. Following the Form 4 filing with the SEC, Maroney has control over a total of 2,276,732 common shares of the company, with 2,276,732 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1832466/000162828025012658/xslF345X05/wk-form4_1741899722.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Gainers
Top Premarket Gainers
Jul 15, 2024
07:50 AM EDT, 07/15/2024 (MT Newswires) -- Scinai Immunotherapeutics ( SCNI ) shares were up nearly 50% pre-bell Monday after the company reported successful results from a pre-clinical trial of a treatment candidate for plaque psoriasis. Trump Media & Technology Group ( DJT ) stock was 48% higher following the weekend after US presidential candidate Donald Trump survived an attempted...
--Street Color: Beam Therapeutics CFO Terry-Ann Burrell Departing in August
--Street Color: Beam Therapeutics CFO Terry-Ann Burrell Departing in August
Jul 15, 2024
07:49 AM EDT, 07/15/2024 (MT Newswires) -- Price: 26.70, Change: -0.18, Percent Change: -0.67 ...
Scinai Immunotherapeutics Shares Surge as Preclinical Data for Psoriasis Therapy Show Promise
Scinai Immunotherapeutics Shares Surge as Preclinical Data for Psoriasis Therapy Show Promise
Jul 15, 2024
07:49 AM EDT, 07/15/2024 (MT Newswires) -- Scinai Immunotherapeutics ( SCNI ) said on Monday that preclinical study results of its experimental therapy for mild to moderate plaque psoriasis showed efficacy. The study's data showed that Scinai's therapy had a non-inferior anti-inflammatory effect on the psoriatic lesions compared to corticosteroids and systemic biologics. The drug developer's shares rose nearly 45%...
Goldman Sachs' Q2 Earnings, Net Revenue Rise; Quarterly Dividend Raised
Goldman Sachs' Q2 Earnings, Net Revenue Rise; Quarterly Dividend Raised
Jul 15, 2024
07:55 AM EDT, 07/15/2024 (MT Newswires) -- Goldman Sachs Group ( GS ) reported Q2 earnings Monday of $8.62 per diluted share, up from $3.08 a year earlier. Analysts polled by Capital IQ expected $8.42. Total net revenue, expressed as the sum of total noninterest income and net interest income, for the quarter ended June 30 was $12.73 billion, up...
Copyright 2023-2026 - www.financetom.com All Rights Reserved